Payer BA - Search Results

1

Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index.

Salzl P, Reiberger T, Ferlitsch M, Payer BA, Schwengerer B, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Salzl P, et al. Among authors: payer ba. Ultraschall Med. 2014 Dec;35(6):528-33. doi: 10.1055/s-0034-1366506. Epub 2014 May 28. Ultraschall Med. 2014. PMID: 24871695

2

New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension.

Schwabl P, Bota S, Salzl P, Mandorfer M, Payer BA, Ferlitsch A, Stift J, Wrba F, Trauner M, Peck-Radosavljevic M, Reiberger T. Schwabl P, et al. Among authors: payer ba. Liver Int. 2015 Feb;35(2):381-90. doi: 10.1111/liv.12623. Epub 2014 Jul 9. Liver Int. 2015. PMID: 24953516

3

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab. Reiberger T, et al. Among authors: payer ba. J Gastroenterol. 2012 May;47(5):561-8. doi: 10.1007/s00535-011-0517-4. Epub 2011 Dec 15. J Gastroenterol. 2012. PMID: 22170417

4

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A. Ferlitsch M, et al. Among authors: payer ba. Hepatology. 2012 Oct;56(4):1439-47. doi: 10.1002/hep.25806. Epub 2012 Aug 27. Hepatology. 2012. PMID: 22532296

5

Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.

Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M. Reiberger T, et al. Among authors: payer ba. Wien Klin Wochenschr. 2012 Jun;124(11-12):395-402. doi: 10.1007/s00508-012-0190-5. Epub 2012 Jun 15. Wien Klin Wochenschr. 2012. PMID: 22699260

6

Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).

Peck-Radosavljevic M, Angermayr B, Datz C, Ferlitsch A, Ferlitsch M, Fuhrmann V, Häfner M, Kramer L, Maieron A, Payer B, Reiberger T, Stauber R, Steininger R, Trauner M, Thurnher S, Ulbrich G, Vogel W, Zoller H, Graziadei I; Austrian Society of Gastroenterology and Hepatology. Peck-Radosavljevic M, et al. Wien Klin Wochenschr. 2013 Apr;125(7-8):200-19. doi: 10.1007/s00508-013-0337-z. Epub 2013 Apr 12. Wien Klin Wochenschr. 2013. PMID: 23579878

7

Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection.

Reiberger T, Rutter K, Ferlitsch A, Payer BA, Hofer H, Beinhardt S, Kundi M, Ferenci P, Gangl A, Trauner M, Peck-Radosavljevic M. Reiberger T, et al. Among authors: payer ba. Clin Gastroenterol Hepatol. 2011 Jul;9(7):602-8.e1. doi: 10.1016/j.cgh.2011.03.002. Epub 2011 Mar 10. Clin Gastroenterol Hepatol. 2011. PMID: 21397726

8

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.

Scheiner B, Mandorfer M, Schwabl P, Payer BA, Bucsics T, Bota S, Aichelburg MC, Grabmeier-Pfistershammer K, Stättermayer A, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T. Scheiner B, et al. Among authors: payer ba. PLoS One. 2015 Nov 23;10(11):e0143429. doi: 10.1371/journal.pone.0143429. eCollection 2015. PLoS One. 2015. PMID: 26599080 Free PMC article.

9

A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.

Reiberger T, Payer BA, Ferlitsch A, Sieghart W, Breitenecker F, Aichelburg MC, Schmied B, Rieger A, Trauner M, Peck-Radosavljevic M; Vienna Hepatic Hemodynamic Lab and Vienna HIV & Liver Study Group. Reiberger T, et al. Among authors: payer ba. Antivir Ther. 2012;17(7):1327-34. doi: 10.3851/IMP2349. Epub 2012 Sep 5. Antivir Ther. 2012. PMID: 22948263

10

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H; Vienna Hepatic Hemodynamic Lab. Reiberger T, et al. Among authors: payer ba. J Hepatol. 2013 May;58(5):911-21. doi: 10.1016/j.jhep.2012.12.011. Epub 2012 Dec 20. J Hepatol. 2013. PMID: 23262249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters